Rheumatology International

, Volume 11, Issue 2, pp 69–72 | Cite as

Activated, cytotoxic lymphocytes in systemic vasculitis

  • A. D. Blann
  • D. G. I. Scott


Peripheral blood lymphocytes from some patients with rheumatoid vasculitis and giant cell arteritis vere cytotoxic in vitro towards endothelial cells, but not fibroblasts. Use of cell surface markers and cell density showed that cytotoxicity correlated with numbers of HLA-DR bearing cells, but not with cells bearing CD3, the transferrin receptor, or less dense lymphocytes. We concluded that activated, cytotoxic lymphocytes were present in the peripheral blood of a sub-set of patients with vasculitis.

Key words

Lymphocyte cytotoxicity Rheumatoid diseases Endothelial cells Fibroblasts 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Janossy G, Duke O, Poulter LW, Panayi G, Bofill, Goldstein G (1981) Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet II:839–842Google Scholar
  2. 2.
    Harris ED (1990) Rheumatoid arthritis: pathophysiology and implications for therapy. N Engl J Med 322:1277–1289Google Scholar
  3. 3.
    Salmon M, Bacon PA, Symmons DPM, Blann AD (1985) Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis. Clin Exp Immunol 62:346–352Google Scholar
  4. 4.
    Yu DTY, Winchester RJ, Fu SM, Gibofsky A, Ko HS, Kunkel HG (1980), Peripheral blood Ia-positive T cells. J Exp Med 151:91–99Google Scholar
  5. 5.
    Bacon PA, Salmon M, Blann A, Scott DGI, Farr M (1984) Lymphocyte sub-populations and NSAID's. Methodological aspects. Inflammation 8:s81-s86Google Scholar
  6. 6.
    Abe T, Takeuchi T, Koide J, Honoso O, Homma M, Morimoto C, Yokchari R (1984) Suppressor T cell function in patients with rheumatoid arthritis complicated by vasculitis. Arthritis Rheum 27:752–759Google Scholar
  7. 7.
    Armstrong RD, Panayi GS (1983) Natural killer activity in inflammatory joint disease. Clin Rheumatol 2:243–249Google Scholar
  8. 8.
    Penschow J, Mackay IR (1980) NK and K cell activity of human blood: differences according to sex, age, and disease. Ann Rheum Dis 39:82–86Google Scholar
  9. 9.
    Goto M, Tanimoto K, Chihara T, Horiuchi Y (1981) Natural cell-mediated cytotoxicity in Sjõgren's syndrome and rheumatoid arthritis. Arthritis Rheum 24:1377–1382Google Scholar
  10. 10.
    Reinitz E, Neighbour PA, Grayzel AL (1982) Natural killer activity of mononuclear cells from rheumatoid patients by a conjugate-binding cytotoxicity assay. Arthritis Rheum 25:1440–1444Google Scholar
  11. 11.
    Combe B, Pope RM, Darnel B, Talal N (1984) Modulation of natural killer cell activity in the rheumatoid joint and peripheral blood. Scand J Immunol 20:551–558Google Scholar
  12. 12.
    Scott DGI, Salmon M, Scott DL et al. (1986) Takayasu's arteritis: A pathogenetic role for cytotoxic T lymphocytes? Clin Rheumatol 5:517–522Google Scholar
  13. 13.
    Rosenchein U, Radnay J, Shoham D, Shainberg A, Klajman A, Rozenszajn LA (1987) Human muscle-derived, tissue specific, myocytotoxic T cell lines in dermatomyositis. Clin Exp Immunol 67:309–318Google Scholar
  14. 14.
    Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Boiko YY, Senyuk OF (1989) Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid. Autoimmunity 3:247–260]Google Scholar
  15. 15.
    Andersson R, Jonsson R, Tarkowski A, Bengtsson BA, Malmvall BE (1987) T cells subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 46:915–923Google Scholar
  16. 16.
    Niinaka T, Okochi T, Watanabe Y, Sakai S, Takahashi Y, Yamamura Y (1978) Lymphocyte function in Wegener's granulomatosis. J Med 9:491–501Google Scholar
  17. 17.
    Rasmussen N, Peterson J, Ralfkiaer A, Avnstrom S, Wiik A (1988) Spontaneous and induced immunoglobulin synthesis and anti-neutrophil cytoplasmic antibodies in Wegener's granulomatosis: relation to leukocyte subpopulations in blood and active lesions. Rheumatol Int 8:153–158Google Scholar
  18. 18.
    Panayi GS, Barnes P (1990) Limiting dilution analysis of autocytotoxicity and autosuppressor T-cells in rheumatoid arthritis. Br J Rheumatol 29:430–432Google Scholar
  19. 19.
    Jaffe EA (1984) Biology of endothelial cells. Nijhoff, Boston, MassGoogle Scholar
  20. 20.
    Masuyama J, Minato N, Kano S (1986) Mechanism of lymphocyte adhesion to human vascular endothelial cells in culture. J Clin Invest 77:1596–1605Google Scholar
  21. 21.
    Pober JS, Gimbrone MA, Cotran RS et al. (1983) Ia expression is inducible by activated T cells and by human gamma interferon. J Exp Med 157:1339–1353Google Scholar
  22. 22.
    Miltenburg AMM, Meijer-Paape ME, Daha MR, Paul LC (1987) Endothelial cell lysis induced by lymphokine-activated human peripheral blood mononuclear cells. Eur J Immunol 17:1383–1386Google Scholar
  23. 23.
    Miltenburg AMM, Meijer-Paape ME, Daha MR, Paul LC (1988) Short-term lymphokine stimulation of human peripheral blood mononuclear cells generates cytolytic activity against endothelial cells: involvement of natural killer cells. Immunology 65:107–112Google Scholar
  24. 24.
    Damle NK, Doyle LV, Bender JR, Bradley EC (1987) Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol 138:1779–1785Google Scholar
  25. 25.
    Bender JR, Pardi R, Karasek MA, Engleman EG (1987) Phenotypic and functional characterisation of lymphocytes that bind human microvascular endothelial cells in vitro. J Clin Invest 79:1679–1688Google Scholar
  26. 26.
    Bensussan A, Meuer SC, Schlossman SF, Reinherz EL (1984) Delineation of an immunoregulatory amplifier population recognising autologous Ia molecules. J Exp Med 159:559–576Google Scholar
  27. 27.
    Tilkin AF, Michon J, Juy D et al. (1987) Autoreactive T cell clones of MHC class II specificities are produced during responses against foreign antigens in man. J Immunol 138:674–679Google Scholar
  28. 28.
    Rosenkrantz K, Dupont B, Flomenberg N (1985) Generation and regulation of autocytotoxicity in mixed lymphocyte cultures: evidence for active suppression of autocytotoxic cells. Proc Natl Acad Sci USA 82:4508–4512Google Scholar
  29. 29.
    Schlesier M, Haas G, Wolff-Vorbeck G, Melchers I, Peter HH (1989) Autoreactive T cells in rheumatic disease (1) Analysis of growth frequencies and autoreactivity of T cells in patients with rheumatoid arthritis and Lyme disease. J Autoimmunity 2:31–49Google Scholar
  30. 30.
    Braakman E, Rotteveel FTM, Bleek G van, Seventer GA van, Lucas CJ (1987) Are MHC class II-restricted cytotoxic T lymphocytes important? Immunol Today 8:265–267Google Scholar
  31. 31.
    Simpson E, Mobraaten L, Chandler P et al. (1978) Cross-reactive cytotoxic responses. J Exp Med 148:1478–1487Google Scholar
  32. 32.
    Lanier LL, Cwirla S, Federspiel N, Phillips JH (1986) Human natural killer cells isolated from peripheral blood do not rearrange T cell antigen receptor β chain genes. J Exp Med 163:209–214Google Scholar
  33. 33.
    Lanier LL, Buck DW, Rhodes L et al. (1988) Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167:1572–1585Google Scholar
  34. 34.
    Thiele DL, Lipsky PE (1989) The role of cell surface recognition structures in the initiation of MHC-unrestricted ‘promiscuous’ killing by T cells. Immunol Today 10:375–381Google Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • A. D. Blann
    • 2
    • 1
  • D. G. I. Scott
    • 3
    • 1
  1. 1.Department of RheumatologyThe Medical SchoolBirminghamUK
  2. 2.Department of SurgeryUniversity Hospital of South ManchesterManchesterUK
  3. 3.Department of RheumatologyNorwich and Norfolk HospitalNorwichUK

Personalised recommendations